Robin Eileene Wagner

US Patent:

20060276771, Dec 7, 2006

Filed:

Jun 6, 2005

Appl. No.:

11/145910

Inventors:

Paul Galley - Cumberland IN, US
Ajay Thukral - Indianapolis IN, US
Siva Chittajallu - Indianapolis IN, US
Robin Wagner - Fishers IN, US
Stefan Weinert - Pendleton IN, US
Steven Bousamra - Carmel IN, US

International Classification:

A61M 31/00

US Classification:

604503000, 604066000

Abstract:

A system providing for user intervention in a medical control arrangement may comprise a first user intervention mechanism responsive to user selection thereof to produce a first user intervention signal, a second user intervention mechanism responsive to user selection thereof to produce a second user intervention signal, and a processor executing a drug delivery algorithm forming part of the medical control arrangement. The processor may be responsive to the first user intervention signal to include an intervention therapy value in the execution of the drug delivery algorithm, and responsive to the second user intervention signal to exclude the intervention therapy value from the execution of the drug delivery algorithm. The medical control arrangement may be a diabetes control arrangement, the drug delivery algorithm may be an insulin delivery algorithm, and the intervention therapy value may be, for example, an intervention insulin quantity or an intervention carbohydrate quantity.

US Patent:

20100331627, Dec 30, 2010

Filed:

Jun 26, 2009

Appl. No.:

12/492801

Inventors:

Ajay Thukral - Indianapolis IN, US
Stefan Weinert - Pendleton IN, US
Robin Wagner - Indianapolis IN, US
Maury Zivitz - Indianapolis IN, US

Assignee:

ROCHE DIAGNOSTICS OPERATIONS, INC. - Indianapolis IN

International Classification:

A61B 5/00

US Classification:

600300

Abstract:

An adherence indication tool for chronic disease self-management and method thereof for measuring adherence or compliance to following or achieving prescribed therapy steps to achieve stated target goals for improved chronic disease self-management are disclosed.

US Patent:

20110208027, Aug 25, 2011

Filed:

Feb 23, 2010

Appl. No.:

12/710430

Inventors:

Robin Wagner - Indianapolis IN, US
Stefan Weinert - Pendleton IN, US
Remmert Laan - Zionsville IN, US
Kurt Waechter - Indianapolis IN, US
Christen Rees - Indianapolis IN, US

Assignee:

Roche Diagnostics Operations, Inc. - Indianapolis IN

International Classification:

A61B 5/145

US Classification:

600365

Abstract:

A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.

US Patent:

20110237918, Sep 29, 2011

Filed:

Feb 23, 2011

Appl. No.:

13/032970

Inventors:

Robin Wagner - Indianapolis IN, US
Christen Rees - Indianapolis IN, US
Craig Atkinson - Frenchs Forest, AU
Abhishek Soni - Indianapolis IN, US
David Duke - Fishers IN, US

International Classification:

A61M 5/00
A61B 5/157

US Classification:

600365, 604 9301

Abstract:

A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.

US Patent:

20130041342, Feb 14, 2013

Filed:

Aug 24, 2012

Appl. No.:

13/593575

Inventors:

Nicole Bernini - Burgdorf, CH
Paul J. Galley - Cumberland IN, US
Stefan Lindegger - Huttwil, CH
John F. Price - McCordsville IN, US
Reto Sigrist - Golaten, CH
Robin S. Wagner - Indianapolis IN, US
Richard W. Wilson - Fortville IN, US

Assignee:

ROCHE DIAGNOSTICS OPERATIONS, INC. - Indianapolis IN

International Classification:

A61M 5/168

US Classification:

604500, 604151

Abstract:

A device and method for delivering insulin to a patient is disclosed. The method includes receiving an amount of insulin to deliver to a patient and beginning delivery of the insulin to the patient. The method further includes monitoring the delivery of the insulin to determine whether the insulin pump is able to deliver the entire amount of insulin and maintaining a timer until the insulin pump recommences the delivery of the insulin. The method includes comparing an amount of time indicated by the timer to a threshold. The method further includes generating a first insulin delivery record indicating that a first amount of insulin was delivered when the amount of time indicated by the timer is less than the threshold and a second insulin record indicating that a second amount of insulin was delivered when the amount of time indicated by the timer is greater than the threshold.

US Patent:

20140019396, Jan 16, 2014

Filed:

Jul 11, 2012

Appl. No.:

13/546447

Inventors:

Peter B. Carlsgaard - Zionsville IN, US
Christen Rees - Indianapolis IN, US
Robin S. Wagner - Indianapolis IN, US

Assignee:

ROCHE DIAGNOSTICS OPERATIONS, INC. - Indianapolis IN

International Classification:

G06N 5/02

US Classification:

706 46

Abstract:

A computer-implemented method is presented for recommending insulin dosage adjustments for a patient having diabetes. The method includes: identifying a plurality of bolus events from patient data; grouping bolus events having a recommended bolus dosage substantially equivalent to the amount of administered insulin into a first subset of bolus events; determining a bolus outcome for each of the bolus events in the first subset of bolus events, where the bolus outcome is expressed in relation to a target range of blood glucose values and is selected from a group including above the target range, in the target range and below the target range; determining whether one of the bolus outcomes is predominant amongst the bolus events in the first subset of bolus events; and generating a recommendation pertaining to insulin dosage for the patient in response to a determination that one of the bolus outcomes is predominant.

US Patent:

20140058237, Feb 27, 2014

Filed:

Aug 24, 2012

Appl. No.:

13/593557

Inventors:

Paul J. Galley - Cumberland IN, US
Alan M. Greenburg - Indianapolis IN, US
Marshall M. Parker - Indianapolis IN, US
John F. Price - McCordsville IN, US
Robin S. Wagner - Indianapolis IN, US
Richard W. Wilson - Fortville IN, US

Assignee:

ROCHE DIAGNOSTICS OPERATIONS, INC. - Indianapolis IN

International Classification:

A61B 5/145

US Classification:

600365

Abstract:

According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.

US Patent:

20140058749, Feb 27, 2014

Filed:

Aug 24, 2012

Appl. No.:

13/593593

Inventors:

Paul J. Galley - Cumberland IN, US
Alan M. Greenburg - Indianapolis IN, US
Marshall M. Parker - Indianapolis IN, US
John F. Price - McCordsville IN, US
Robin S. Wagner - Indianapolis IN, US
Richard W. Wilson - Fortville IN, US

Assignee:

ROCHE DIAGNOSTICS OPERATIONS, INC. - Indianapolis IN

International Classification:

G06Q 50/24

US Classification:

705 3

Abstract:

According to some aspects of the present disclosure a method for presenting a GUI for modifying medical data on a handheld medical device is disclosed. The method includes determining a correction bolus amount and a meal bolus amount for the patient. The method also includes presenting the GUI on a display of the medical device and presenting the correction bolus amount, the meal bolus amount and a total bolus amount in the GUI. The method also includes presenting a correction bolus amount modification field and a meal bolus amount field in the GUI. The correction bolus amount modification field and the meal bolus amount modification field allow the patient to provide input to modify the correction bolus amount and meal bolus amount, respectively. The method further includes receiving the input and generating an advice history record based on the input.